Parkinson's Disease (PD) Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Parkinson's Disease (PD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Accelerated TMS for Freezing of Gait in Parkinson's Disease

Parkinson's Disease (PD)
Medical University of South Carolina12 enrolled1 locationNCT06982638
Recruiting
Not Applicable

Attention and Eye Movement in Parkinson's Disease

Parkinson's Disease (PD)Essential Tremor
University of Nebraska138 enrolled1 locationNCT06899022
Recruiting
Phase 4

Clozapine-related Immunodeficiency in Parkinsons Disease

ImmunodeficiencyPsychosisParkinson's Disease (PD)+1 more
Centre Hospitalier Universitaire, Amiens24 enrolled1 locationNCT06634641
Recruiting
Not Applicable

Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases

Parkinson DiseaseAlzheimer's Disease (AD)Mild Cognitive Impairment+4 more
Sanmai Technologies PBC dba Sanmai20 enrolled1 locationNCT07207122
Recruiting
Not Applicable

Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

Parkinson's Disease (PD)
Weill Medical College of Cornell University40 enrolled1 locationNCT06975059
Recruiting
Phase 1Phase 2

Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)

Parkinson's Disease (PD)
EicOsis Human Health Inc.18 enrolled1 locationNCT07142044
Recruiting
Not Applicable

Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop

Deep Brain StimulationParkinson's Disease (PD)
Universitätsklinikum Hamburg-Eppendorf2 enrolled1 locationNCT07139093
Recruiting

Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults

Parkinson's Disease (PD)
University of Haifa180 enrolled1 locationNCT06932679
Recruiting
Not Applicable

CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease

Parkinson's Disease (PD)
Northumbria University60 enrolled2 locationsNCT06941779
Recruiting

Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene

Idiopathic Parkinson's Disease (PD)
Azienda USL Reggio Emilia - IRCCS3,000 enrolled4 locationsNCT06814431
Recruiting
Not Applicable

Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

Parkinson's Disease (PD)
Xuanwu Hospital, Beijing180 enrolled1 locationNCT06742450